Cargando…
An Interesting Case Report of Myasthenia Gravis Exacerbation Induced by Durvalumab
Immune checkpoint inhibitors are novel therapy for a wide range of malignancies. They have been associated with numerous side effects resulting in pulmonary, dermatological, gastrointestinal, and neurological complications. There are few reported cases of myasthenia gravis exacerbation from immune c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381854/ https://www.ncbi.nlm.nih.gov/pubmed/35989744 http://dx.doi.org/10.7759/cureus.26985 |